Ropinirole Hydrochloride
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Ropinirole Hydrochloride contains NLT 98.0% and NMT 102.0% of ropinirole hydrochloride (C₁₆H₂₄N₂O · HCl), calculated on the anhydrous and solvent-free basis.
2 IDENTIFICATION
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
Change to read:
C. Identification Tests—General 〈191〉, Chemical Identification Tests, Chloride
Sample: 20 mg/mL of Ropinirole Hydrochloride in water ▲(USP 1-May-2021)
Acceptance criteria: Meets the requirements ▲ (USP 1-May-2021)
3 ASSAY
Change to read:
Procedure
Buffer: 1.88 g of sodium 1-hexanesulfonate and 1 g of phosphoric acid in 1 L of water. Adjust with dilute triethylamine solution (1:10) to a pH of 6.5.
Diluent: Acetonitrile and water (20:80)
Mobile phase: Acetonitrile and Buffer (20:80)
Standard solution: 0.1 mg/mL of USP Ropinirole Hydrochloride RS in Diluent. Sonication may be used to aid dissolution.
Sample solution: 0.1 mg/mL of Ropinirole Hydrochloride in Diluent. Sonication may be used to aid dissolution.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 215 nm
Column: 4.6-mm × 25-cm; 5-µm packing L7
Column temperature: 30°
Flow rate: 1.0 mL/min
Injection volume: 10 µL
Run time: NLT (USP 1-May-2021) 2.5 times the retention time of ropinirole
System suitability
Sample: Standard solution
Suitability requirements:
Tailing factor: NMT 1.6
Relative standard deviation: NMT 1.0% (USP 1-May-2021)
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of ropinirole hydrochloride (C₁₆H₂₄N₂O · HCl):
Result = (rᵤ / rₛ) × (Cₛ / Cᵤ) × 100
rᵤ = peak response from the Sample solution
rₛ = peak response from the Standard solution
Cₛ = concentration of the Standard solution (mg/mL)
Cᵤ = concentration of the Sample solution (mg/mL)
Acceptance criteria: 98.0%–102.0%, anhydrous and solvent-free basis.
4 IMPURITIES
Residue on Ignition 〈281〉
NMT 0.1%
Change to read: Limit of Palladium
[Note—Perform this test if Palladium is a known inorganic impurity.]
Solution A: Dissolve 2.4 g sodium hydroxide in 20 mL water and dilute with Glycerin (USP 1-May-2021) to 100 mL.
Solution B: 40 mg/mL thioacetamide in water.
Buffer: Carefully add 27 mL HCl to 25 g ammonium acetate; dilute to 100 mL.
Palladium standard solution: 10 ppm Pd (from ICP 1000 ppm stock).
Standard solution: Process as described; ignite, dissolve, filter (2 µm).
Sample solution: Carbonize 1 g sample; digest; filter (2 µm).
Analysis:
Add 1 mL Solution A, 0.2 mL Solution B, 2 mL Buffer → incubate 37° for 2 h → filter.
Acceptance criteria: Sample spot ≤ standard spot (10 ppm).
Organic Impurities — Procedure 1
Buffer, Diluent: As in Assay.
Solution A: Acetonitrile and Buffer (15:85)
Solution B: Acetonitrile and water (60:40)
Mobile phase: Table 1
| Time (min) | Solution A (%) | Solution B (%) |
|---|---|---|
| 0 | 100 | 0 |
| 5 | 100 | 0 |
| 30 | 60 | 40 |
| 50 | 60 | 40 |
| 55 | 100 | 0 |
| 65 | 100 | 0 |
System suitability solution: 1 mg/mL USP Ropinirole Hydrochloride RS + 1.5 µg/mL Ropinirole Related Compound B RS.
Sample solution: 1 mg/mL in Diluent.
Chromatographic system
Detector: UV 215 nm
Column: L7, 4.6-mm × 25-cm
Column temp: 30°
Flow: 1 mL/min
Injection: 10 µL
System suitability
Resolution: NLT 1.5 (ropinirole vs compound B)
Tailing factor: NMT 2.0
RSD: NMT 2.0%
Analysis
Result = (rᵤ / rₜ) × (1/F) × 100
rᵤ = peak of each impurity
rₜ = total peak area
F = relative response factor
Acceptance criteria: See Table 2.
| Name | RRT | RRF | NMT (%) |
|---|---|---|---|
| Open ring nitro derivativeᵃ | 0.39 | 0.72 | 0.15 |
| Monopropyl ropiniroleᵇ | 0.58 | 1.1 | 0.15 |
| N-Hydroxyropiniroleᶜ | 0.84 | 0.65 | 0.15 |
| Ropinirole related compound B | 0.97 | 0.66 | 0.15 |
| Ropinirole | 1.0 | — | — |
| Any individual unknown impurity | — | 1.0 | 0.10 |
| Total impuritiesᵈ | — | — | 1.0 |
ᵃ 2-{2-[2-(Dipropylamino)ethyl]-6-nitrophenyl}acetic acid
ᵇ 4-[2-(Propylamino)ethyl]indolin-2-one
ᶜ 4-[2-(Dipropylamino)ethyl]-1-hydroxyindolin-2-one
ᵈ Includes impurities ≥ 0.05%
Organic Impurities — Procedure 2
Solution A: 3.85 g/L ammonium acetate; adjust pH 2.5 with phosphoric acid
Solution B: Acetonitrile/methanol (70:30)
Diluent: A:B (84:16)
Mobile phase: Table 3
| Time (min) | A (%) | B (%) |
|---|---|---|
| 0 | 84 | 16 |
| 16 | 84 | 16 |
| 36 | 20 | 80 |
| 37 | 84 | 16 |
| 51 | 84 | 16 |
System suitability solution: 0.05 mg/mL each of Ropinirole Hydrochloride RS, Related Compound A RS, Related Compound B RS.
Standard solution: 3 µg/mL Related Compound B RS.
Sample solution: 1 mg/mL.
System suitability
Resolution:
NLT 2.0 (compound A vs compound B)
NLT 3.0 (compound B vs ropinirole)
Tailing factor: NMT 1.5
RSD: NMT 5.0% (compound B)
Analysis
Ropinirole Related Compound B
Result = (rᵤ / rₛ) × (Cₛ / Cᵤ) × 100
Other impurities:
Result = (rᵤ / rₜ) × 100
Acceptance criteria: See Table 4.
| Name | RRT | NMT (%) |
|---|---|---|
| Monopropyl ropiniroleᵃ | 0.37 | 0.2 |
| Ropinirole related compound Aᵇ | 0.70 | — |
| Ropinirole related compound B | 0.85 | 0.3 |
| Ropinirole | 1.0 | — |
| Methylene ropiniroleᶜ | 1.39 | 0.2 |
| Ropinirole isohexyl analogᵈ | 1.64 | 0.3 |
| Propylidene ropiniroleᵉ | 1.70 | 0.2 |
| Any individual unspecified impurity | — | 0.10 |
| Total impurities | — | 1.0 |
ᵃ 4-[2-(Propylamino)ethyl]indolin-2-one
ᵇ For system suitability only
ᶜ 4-[2-(Dipropylamino)ethyl]-3-methyleneindolin-2-one
ᵈ 4-[2-(2-Methylpentylamino)ethyl]indolin-2-one
ᵉ (Z)-4-[2-(Dipropylamino)ethyl]-3-propylideneindolin-2-one
Organic Impurities — Procedure 3
Solution A: 3.95 g ammonium bicarbonate / 990 mL water + 4 mL 25% ammonia → dilute to 1 L (pH 9.2–9.3)
Solution B: Acetonitrile
Diluent: Acetonitrile/water (32:68)
Mobile phase: Table 5
Table 5
| Time (min) | A (%) | B (%) |
|---|---|---|
| 0 | 68 | 32 |
| 12 | 68 | 32 |
| 28 | 20 | 80 |
| 34 | 20 | 80 |
| 34.1 | 68 | 32 |
| 40 | 68 | 32 |
System suitability solution: 1 mg/mL Ropinirole HCl RS + 0.01 mg/mL Related Compound B RS
Standard solution: 1.2 µg/mL Ropinirole HCl RS
Sample solution: 1.2 mg/mL
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 220 nm
Column: 3.9-mm × 15-cm; 5-µm packing L1
Flow rate: 1 mL/min
Injection volume: 20 µL
System suitability
Samples: System suitability solution and Standard solution
Suitability requirements
Resolution: NLT 1.5 between ropinirole and ropinirole related compound B, System suitability solution
Tailing factor: 0.8–1.5 for ropinirole, Standard solution
Relative standard deviation: NMT 5.0% for ropinirole, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of any individual impurity in the portion of Ropinirole Hydrochloride taken:
Analysis
Result = (rᵤ / rₛ) × (Cₛ / Cₛ ) × (1/F) × 100
rᵤ = peak response ▲of each individual impurity▲ (USP 1-May-2021) from the Sample solution
rₛ= peak response ▲of ropinirole▲ (USP 1-May-2021) from the Standard solution
Cₛ = concentration of the Standard solution (mg/mL)
Cₛ = concentration of the Sample solution (mg/mL)
F = relative response factor (see Table 6)
Acceptance criteria: Table 6.
| Name | RRT | RRF | NMT (%) |
|---|---|---|---|
| Ropinirole oximeᵃ | 0.69 | 1.0 | 0.15 |
| Ropinirole | 1.0 | — | — |
| Ropinirole related compound B | 1.2 | 1.0 | 0.15 |
| Ropinirole indole derivativeᵇ | 2.0 | 4.0 | 0.10 |
| Any individual unspecified impurity | — | — | 0.10 |
| Total impurities | — | — | 0.50 |
ᵃ 4-[2-(Dipropylamino)ethyl]-3-(hydroxyimino)indolin-2-one
ᵇ N,N-Dipropyl-N-(2-indol-4-ylethyl)amine
5 SPECIFIC TESTS
Water Determination 〈921〉, Method I, Method Ic: NMT 0.5%
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in well-closed containers; store at room temperature.
Labeling: Label states Organic Impurities procedure used if not Procedure 1.
USP Reference Standards 〈11〉
USP Ropinirole Hydrochloride RS
USP Ropinirole Related Compound A RS
4-(2-Hydroxyethyl)indolin-2-one C₁₀H₁₁NO₂ 177.20
USP Ropinirole Related Compound B RS
4-[2-(Dipropylamino)ethyl]indoline-2,3-dione hydrochloride
C₁₆H₂₂N₂O₂ · HCl 310.82

